Key result
AF ablation carries a 0.16% symptomatic embolic event rate, with higher risk linked to laserballoon use.
Why the study?
What is the incidence, timing, and clinical outcome of symptomatic stroke and systemic embolism following AF and left AFL catheter ablation?
Observational (n=335,743)
Yes
What is the incidence, timing, and clinical outcome of symptomatic stroke and systemic embolism following AF and left AFL catheter ablation?
Symptomatic embolic events after AF ablation are rare (0.16%) but carry significant morbidity, with risk varying by AF type, center experience, and ablation energy source.
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The study found that symptomatic embolic events occur in just 0.16% of cases. … Most occurred within 72 hours post-procedure, yet 23% were only diagnosed after hospital discharge. … Outcomes remain significant: 35% experienced lasting sequelae and 3% mortality at 3 months.”
“EMBOL-AF is a reminder that rare does not mean trivial. Symptomatic stroke/systemic embolism after AF ablation was just 0.16%—but 23% were diagnosed after discharge, 35% had persistent sequelae, and 3% died. Process still matters.”
“Has the field focused too much on energy source and not enough on workflow, anticoagulation quality, sheath handling, and post-discharge vigilance?”
Emphasizes workflow, anticoagulation, and post-discharge vigilance in AF ablation; hypothesis-generating for increased risk with pulsed field and laser balloon modalities.
Background and Aims Stroke and systemic embolism are recognized but poorly characterized complications of atrial fibrillation (AF) and left atrial flutter (AFL) catheter ablation. Their incidence, outcomes, and procedural associations remain insufficiently defined. Methods Retrospective global registry was initiated by the European Heart Rhythm Association Scientific Committee. A secure database captured data from ablation centres worldwide on general AF and left AFL ablation activity, as well as detailed information on patients with symptomatic embolic events between 2017 and 2024. Results Overall, 204 centres reported 335 743 ablation procedures and 550 embolic events (incidence 0.16%). Centre-level rate ranged from 0% to 3.1%. Most events were cerebral (94%), followed by peripheral (5%), and combined (1%). Coronary air embolism accounted for 62% of all peripheral events. Intraprocedural events occurred in 93 patients (17%), within 72 h in 357 (78%) and beyond 72 h in 100 (22%); 128 cases (23%) were diagnosed after hospital discharge. Nonparoxysmal AF (0.23% vs 0.15%; P < .001), centre experience, and ablation energy source (radiofrequency, 0.16%; cryoballoon, 0.16%; pulsed field ablation, 0.25%; laserballoon, 0.88%; P < .001) were associated with embolic risk. Median NIHSS score after stroke was 4 (interquartile range, 2–9). Three-month follow-up was available for 518 patients with embolism (95%): 181 (35%) had sequelae and 16 (3%) died. Conclusions Symptomatic embolic events are infrequent but associated with significant morbidity and mortality. Most events occur early, though a substantial proportion arise later. Higher event rates were observed with laser and possibly with pulsed field ablation. A greater centre experience was associated with a lower embolism incidence.
Castrejón-Castrejón et al. (2026) conducted an observational in Atrial fibrillation and left atrial flutter (n=335,743). Catheter ablation was evaluated on Symptomatic embolic events. Symptomatic embolic events after AF ablation occurred in 0.16% of procedures, with higher rates for nonparoxysmal AF (0.23% vs 0.15%; P<0.001) and laserballoon ablation (0.88%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: